Related Experiment Video
Updated: May 12, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
[Antigen vaccines in melanoma: Towards a new therapeutic paradigm]
Clément Svabek1, Sophie Maiezza1, Eve Desmedt1
1Service de dermatologie, université Lille, CHU Lille, 59000 Lille, France.
Abstract:
Locally advanced or metastatic melanoma is a cancer with a poor prognosis, characterised by its ability to respond to the induction of an immune response. Anti-tumour vaccination has been studied for many years, although initial results have sometimes been disappointing. The emergence of immune checkpoint inhibiting immunotherapies has dramatically changed the prognosis. Melanoma has emerged as a prime model for renewed research into anti-tumour vaccination. The aim of this review article is to provide an overview of recent developments and prospects for antigen vaccines in the treatment of melanoma. We will explore their mechanism of action, the results of recent clinical trials, and the limitations and challenges of this new therapeutic approach.
Insights
Antigen vaccines show promise for treating advanced melanoma by harnessing the immune system. Recent advancements in immunotherapy are revitalizing this approach, offering new hope for patients with this challenging cancer.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

